منابع
1-Larijani BZ, Zahedi F. Epidemiology of diabetes mellitus in Iran. Iranian Journal of diabetes and lipid disorders. 2002; 1: 1-8.
2-
Ziegler D. Painful diabetic neuropathy, advantage of novel drugs over old drugs?. diabetes care. 2009; 32(suppl2): s414-19. [PMID: 19875591]
3-Mary MH, Amanda P. Painful diabetic neuropathy: A management–centered review. clinical diabetes. 2007; 25: 6-15.
4-Aaron V. Use of Antiepileptic Drugs in the treatment of chronic painful diabetic neuropathy. Journal of clinical endocrinology & metabolism. 2005; 90(8): 4936- 45.
5-Gomez FJ, Choza R, Rios JM, Reza A, Huerta E, Aguilar CA, et al. Nortriptyline - flupherazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Rec. 1996; 27(4): 525-9. [PMID: 8987189]
6-Jennifer RL. Management of painful diabetic neuropathy: focus on tricyclic, antidepressants and gabapentin. P&T News. 2001; 15: 525-7.
9-Jia HY, Li QF. Effects of venlafaxine and carbamazepine for painful peripheral diabetic neuropathy: A randomized double blind and double dummy. Controlled multi-center trial. 2006; 6: 321-30.
10-Zachary S, Eva F. The pharmacological treatment of painful diabetic neuropathy. Clinical diabetes. 2000; 18(3): 34-45.